Bill Text: TX HB2906 | 2015-2016 | 84th Legislature | Introduced

---

Bill Title: Relating to certain diagnostic testing during pregnancy.

Sponsorship: Partisan Bill (Republican 1)

Status: (Introduced - Dead) 2015-05-11 - Laid on the table subject to call [HB2906 Detail]

Download: Texas-2015-HB2906-Introduced.html

---

84R8400 LED-F
By: Davis of Harris H.B. No. 2906

A BILL TO BE ENTITLED
AN ACT
relating to certain diagnostic testing during pregnancy.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. Sections 81.090(a-1), (c), (c-1), and (c-2),
Health and Safety Code, are amended to read as follows:
(a-1) A physician or other person permitted by law to attend
a pregnant woman during gestation or at delivery of an infant shall:
(1) take or cause to be taken a sample of the woman's
blood or other appropriate specimen at an examination in the third
trimester of the pregnancy;
(2) submit the sample to an appropriately certified
laboratory for a diagnostic test approved by the United States Food
and Drug Administration for syphilis and HIV infection; and
(3) retain a report of each case for nine months and
deliver the report to any successor in the case.
(c) A physician or other person in attendance at a delivery
shall:
(1) take or cause to be taken a sample of blood or
other appropriate specimen from the mother on admission for
delivery; and
(2) submit the sample to an appropriately certified
laboratory for diagnostic testing approved by the United States
Food and Drug Administration for[:
[(A) syphilis; and
[(B)] hepatitis B infection.
(c-1) If the physician or other person in attendance at the
delivery does not find in the woman's medical records results from
the diagnostic test for syphilis and HIV infection performed under
Subsection (a-1), the physician or person shall:
(1) take or cause to be taken a sample of blood or
other appropriate specimen from the mother;
(2) submit the sample to an appropriately certified
laboratory for diagnostic testing approved by the United States
Food and Drug Administration for syphilis and HIV infection; and
(3) instruct the laboratory to expedite the processing
of the test so that the results are received less than six hours
after the time the sample is submitted.
(c-2) If the physician or other person in attendance at the
delivery does not find in the woman's medical records results from a
diagnostic test for syphilis and HIV infection performed under
Subsection (a-1), and the diagnostic test for syphilis and HIV
infection was not performed before delivery under Subsection (c-1),
the physician or other person in attendance at delivery shall:
(1) take or cause to be taken a sample of blood or
other appropriate specimen from the newborn child less than two
hours after the time of birth;
(2) submit the sample to an appropriately certified
laboratory for a diagnostic test approved by the United States Food
and Drug Administration for syphilis and HIV infection; and
(3) instruct the laboratory to expedite the processing
of the test so that the results are received less than six hours
after the time the sample is submitted.
SECTION 2. Sections 81.090(a-1), (c), (c-1), and (c-2),
Health and Safety Code, as amended by this Act, apply only to
submission of a sample for diagnostic testing on or after the
effective date of this Act. The submission of a sample for
diagnostic testing before the effective date of this Act is covered
by the law in effect immediately before the effective date of this
Act, and the former law is continued in effect for that purpose.
SECTION 3. This Act takes effect September 1, 2015.